Stimulant use disorder diagnosis and opioid agonist treatment dispensation following release from prison: a cohort study
Abstract Background Concurrent opioid and stimulant use is on the rise in North America. This increasing trend of use has been observed in the general population, and among people released from prison in British Columbia (BC), who face an elevated risk of overdose post-release. Opioid agonist treatm...
Main Authors: | Heather Palis, Bin Zhao, Pam Young, Mo Korchinski, Leigh Greiner, Tonia Nicholls, Amanda Slaunwhite |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-11-01
|
Series: | Substance Abuse Treatment, Prevention, and Policy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13011-022-00504-z |
Similar Items
-
Barriers and facilitators to opioid agonist treatment (OAT) engagement among individuals released from federal incarceration into the community in Ontario, Canada
by: Cayley Russell, et al.
Published: (2022-12-01) -
Applying the socio-ecological model to understand community reintegration experiences among individuals on opioid agonist treatment (OAT) released from federal incarceration in Ontario, Canada
by: Cayley Russell, et al.
Published: (2022-12-01) -
Mental health services access and reincarceration following release from provincial prisons in British Columbia, Canada.
by: Heather Palis, et al.
Published: (2022-08-01) -
Is use of opioid agonist treatment associated with broader primary healthcare use among men with recent injecting drug use histories following release from prison? A prospective cohort study
by: Michael Curtis, et al.
Published: (2023-03-01) -
Medications for opioid use disorder during incarceration and post-release outcomes
by: Lara Cates, et al.
Published: (2023-02-01)